查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1738437

維生素 B9 市場 - 全球產業規模、佔有率、趨勢、機會和預測，按銷售管道（直接、間接）、最終用途（醫藥、食品、動物飼料、化妝品和個人護理、其他）、按地區和競爭細分，2020-2030 年預測

Vitamin B9 Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Sales Channel (Direct, Indirect), By End Use (Pharmaceutical, Food, Animal Feed,Cosmetic & Personal Care, Others), By Region and Competition, 2020-2030F
出版日期: | 出版商: TechSci Research | 英文 185 Pages | 商品交期: 2-3個工作天內

價格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

簡介目錄

2024 年全球維生素 B9 市值為 8,710 萬美元，預計到 2030 年將達到 1.0691 億美元，複合年成長率為 2.45%。維生素 B9，也稱為葉酸，對 DNA 合成、紅血球生成和胎兒發育至關重要，使其成為生命各個階段（尤其是在懷孕期間）的關鍵營養素。對預防性醫療保健的日益關注和消費者對營養缺乏症的認知的提高，推動了對維生素 B9 補充劑的需求，尤其是在北美和歐洲。旨在減少新生兒貧血和神經管缺陷的政府措施進一步鼓勵了葉酸的強化和補充。然而，市場面臨監管複雜性、原料價格波動以及過量攝取的潛在副作用等障礙。儘管存在這些挑戰，持續的研發投資、策略合作夥伴關係以及向滲透不足地區的擴張預計將塑造市場的成長軌跡。

市場概覽
預測期 2026-2030
2024年市場規模 8710萬美元
2030年市場規模 1.0691億美元
2025-2030 年複合年成長率 2.45%
成長最快的領域 直接的
最大的市場 北美洲

關鍵市場促進因素

製藥業的成長

主要市場挑戰

原料供應中斷

主要市場趨勢

膳食補充劑需求不斷成長

目錄

第 1 章：產品概述

第2章：研究方法

第3章：執行摘要

第4章：COVID-19 對全球維生素 B9 市場的影響

第5章：全球維生素B9市場展望

  • 市場規模和預測
    • 按價值
  • 市場佔有率和預測
    • 按銷售管道（直接、間接）
    • 依最終用途（醫藥、食品、動物飼料、化妝品和個人護理、其他）
    • 按地區
    • 按公司分類（2024）
  • 市場地圖

第6章：北美維生素B9市場展望

  • 市場規模和預測
  • 市場佔有率和預測
  • 北美：國家分析
    • 美國
    • 墨西哥
    • 加拿大

第7章：歐洲維生素B9市場展望

  • 市場規模和預測
  • 市場佔有率和預測
  • 歐洲：國家分析
    • 法國
    • 德國
    • 英國
    • 義大利
    • 西班牙

第8章：亞太維生素B9市場展望

  • 市場規模和預測
  • 市場佔有率和預測
  • 亞太地區：國家分析
    • 中國
    • 印度
    • 韓國
    • 日本
    • 澳洲

第9章：南美維生素B9市場展望

  • 市場規模和預測
  • 市場佔有率和預測
  • 南美洲：國家分析
    • 巴西
    • 阿根廷
    • 哥倫比亞

第10章：中東與非洲維生素B9市場展望

  • 市場規模和預測
  • 市場佔有率和預測
  • MEA：國家分析
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國

第 11 章：市場動態

  • 驅動程式
  • 挑戰

第 12 章：市場趨勢與發展

  • 合併與收購（如有）
  • 產品發布（如有）
  • 最新動態

第 13 章：全球維生素 B9 市場：SWOT 分析

第 14 章：波特五力分析

  • 產業競爭
  • 新進入者的潛力
  • 供應商的力量
  • 顧客的力量
  • 替代產品的威脅

第 15 章：競爭格局

  • Anhui Xinhong Chemical Co., Ltd
  • Changzhou Niutang Chemical Plant Co., Ltd.
  • Zhejiang Shengda Bio-Pharm Co., Ltd.
  • Xinfa Pharmaceutical Co., Ltd.
  • Jiangxi Tianxin Pharmaceutical Co., Ltd.
  • Hebei Jiheng (Group) Pharmaceutical Co., Ltd.

第 16 章：策略建議

第17章調查會社について,免責事項

簡介目錄
Product Code: 29288

The Global Vitamin B9 Market was valued at USD 87.10 Million in 2024 and is projected to reach USD 106.91 Million by 2030, growing at a CAGR of 2.45%. Vitamin B9, also known as folate or folic acid, is essential for DNA synthesis, red blood cell production, and fetal development, making it a critical nutrient across various life stages, particularly during pregnancy. Rising focus on preventive healthcare and increased consumer awareness about nutritional deficiencies are driving demand for Vitamin B9 supplements, especially in North America and Europe. Government initiatives aimed at reducing anemia and neural tube defects in newborns have further encouraged folic acid fortification and supplementation. However, the market faces obstacles such as regulatory complexities, raw material price fluctuations, and the potential side effects of excessive intake. Despite these challenges, ongoing R&D investments, strategic partnerships, and expansion into underpenetrated regions are expected to shape the market's growth trajectory.

Market Overview
Forecast Period2026-2030
Market Size 2024USD 87.10 Million
Market Size 2030USD 106.91 Million
CAGR 2025-20302.45%
Fastest Growing SegmentDirect
Largest MarketNorth America

Key Market Drivers

Growth in Pharmaceutical Industry

The expanding pharmaceutical industry serves as a key driver for the Vitamin B9 market, fueled by the sector's focus on disease prevention, prenatal health, and nutritional therapies. By 2023, the pharmaceutical market had reached revenues of approximately USD 1.6 trillion, highlighting its global scale and influence. Vitamin B9 is indispensable in therapeutic applications due to its roles in cell division, DNA synthesis, and hematopoiesis. It is extensively used in prenatal supplements to prevent neural tube defects and is increasingly incorporated into treatments for anemia, cognitive decline, and cardiovascular health. The market has seen innovations like Manna iStrong, a fortified drink launched by Southern Health Foods Pvt Ltd. in India, which delivers 100% of the RDA for Vitamin B9 among others. In regions where fortified foods are less accessible, pharmaceutical-grade supplements are vital, particularly in maternal and elderly care segments.

Key Market Challenges

Raw Material Supply Disruptions

Raw material supply instability presents a significant hurdle for Vitamin B9 manufacturers. The market is highly dependent on specific chemical intermediates and ingredients, predominantly sourced from a few global suppliers. Events such as geopolitical tensions, trade regulations, and natural disasters, as well as pandemics like COVID-19, have exposed vulnerabilities in the global supply chain. Countries such as China and India play critical roles in supplying active pharmaceutical ingredients (APIs) and intermediates, meaning regulatory changes or environmental policy shifts in these regions can disrupt production. These constraints not only elevate costs but also introduce delays and uncertainty for manufacturers, particularly small and medium-sized enterprises.

Key Market Trends

Increasing Demand for Dietary Supplements

The growing global emphasis on preventive healthcare is fueling demand for dietary supplements, making it a defining trend in the Vitamin B9 market. Consumers are increasingly turning to supplements to support immune function, address nutritional gaps, and reduce disease risk. Folic acid's inclusion in multivitamins and prenatal products is becoming more common due to its crucial role in cellular health, red blood cell formation, and fetal development. Products like Merck's Arcofolin L-Methylfolate represent a new generation of folate supplements designed for enhanced bioavailability and metabolic efficiency. This trend is particularly pronounced in North America, Europe, and emerging markets in Asia-Pacific, where health-conscious lifestyles and increased awareness are driving consistent growth in the consumption of Vitamin B9-enriched supplements.

Key Market Players

  • Anhui Xinhong Chemical Co., Ltd
  • Changzhou Niutang Chemical Plant Co., Ltd.
  • Zhejiang Shengda Bio-Pharm Co., Ltd.
  • Xinfa Pharmaceutical Co., Ltd.
  • Jiangxi Tianxin Pharmaceutical Co., Ltd.
  • Hebei Jiheng (Group) Pharmaceutical Co., Ltd.

Report Scope

In this report, the Global Vitamin B9 Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Vitamin B9 Market, By Sales Channel:

  • Direct
  • Indirect

Vitamin B9 Market, By End Use:

  • Pharmaceutical
  • Food
  • Animal Feed
  • Cosmetic & Personal Care
  • Others

Vitamin B9 Market, By Region:

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • France
    • United Kingdom
    • Italy
    • Germany
    • Spain
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Vitamin B9 Market.

Available Customizations

Global Vitamin B9 Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, and Trends

4. Impact of COVID-19 on Global Vitamin B9 Market

5. Global Vitamin B9 Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Sales Channel (Direct, Indirect)
    • 5.2.2. By End Use (Pharmaceutical, Food, Animal Feed ,Cosmetic & Personal Care, Others)
    • 5.2.3. By Region
    • 5.2.4. By Company (2024)
  • 5.3. Market Map

6. North America Vitamin B9 Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Sales Channel
    • 6.2.2. By End Use
    • 6.2.3. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Vitamin B9 Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Sales Channel
        • 6.3.1.2.2. By End Use
    • 6.3.2. Mexico Vitamin B9 Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Sales Channel
        • 6.3.2.2.2. By End Use
    • 6.3.3. Canada Vitamin B9 Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Sales Channel
        • 6.3.3.2.2. By End Use

7. Europe Vitamin B9 Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Sales Channel
    • 7.2.2. By End Use
    • 7.2.3. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. France Vitamin B9 Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Sales Channel
        • 7.3.1.2.2. By End Use
    • 7.3.2. Germany Vitamin B9 Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Sales Channel
        • 7.3.2.2.2. By End Use
    • 7.3.3. United Kingdom Vitamin B9 Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Sales Channel
        • 7.3.3.2.2. By End Use
    • 7.3.4. Italy Vitamin B9 Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Sales Channel
        • 7.3.4.2.2. By End Use
    • 7.3.5. Spain Vitamin B9 Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Sales Channel
        • 7.3.5.2.2. By End Use

8. Asia Pacific Vitamin B9 Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Sales Channel
    • 8.2.2. By End Use
    • 8.2.3. By Country
  • 8.3. Asia Pacific: Country Analysis
    • 8.3.1. China Vitamin B9 Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Sales Channel
        • 8.3.1.2.2. By End Use
    • 8.3.2. India Vitamin B9 Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Sales Channel
        • 8.3.2.2.2. By End Use
    • 8.3.3. South Korea Vitamin B9 Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Sales Channel
        • 8.3.3.2.2. By End Use
    • 8.3.4. Japan Vitamin B9 Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Sales Channel
        • 8.3.4.2.2. By End Use
    • 8.3.5. Australia Vitamin B9 Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Sales Channel
        • 8.3.5.2.2. By End Use

9. South America Vitamin B9 Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Sales Channel
    • 9.2.2. By End Use
    • 9.2.3. By Country
  • 9.3. South America: Country Analysis
    • 9.3.1. Brazil Vitamin B9 Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Sales Channel
        • 9.3.1.2.2. By End Use
    • 9.3.2. Argentina Vitamin B9 Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Sales Channel
        • 9.3.2.2.2. By End Use
    • 9.3.3. Colombia Vitamin B9 Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Sales Channel
        • 9.3.3.2.2. By End Use

10. Middle East and Africa Vitamin B9 Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Sales Channel
    • 10.2.2. By End Use
    • 10.2.3. By Country
  • 10.3. MEA: Country Analysis
    • 10.3.1. South Africa Vitamin B9 Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Sales Channel
        • 10.3.1.2.2. By End Use
    • 10.3.2. Saudi Arabia Vitamin B9 Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Sales Channel
        • 10.3.2.2.2. By End Use
    • 10.3.3. UAE Vitamin B9 Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Sales Channel
        • 10.3.3.2.2. By End Use

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Merger & Acquisition (If Any)
  • 12.2. Product Launches (If Any)
  • 12.3. Recent Developments

13. Global Vitamin B9 Market: SWOT Analysis

14. Porters Five Forces Analysis

  • 14.1. Competition in the Industry
  • 14.2. Potential of New Entrants
  • 14.3. Power of Suppliers
  • 14.4. Power of Customers
  • 14.5. Threat of Substitute Products

15. Competitive Landscape

  • 15.1. Anhui Xinhong Chemical Co., Ltd
    • 15.1.1. Business Overview
    • 15.1.2. Company Snapshot
    • 15.1.3. Products & Services
    • 15.1.4. Financials (As Reported)
    • 15.1.5. Recent Developments
    • 15.1.6. Key Personnel Details
    • 15.1.7. SWOT Analysis
  • 15.2. Changzhou Niutang Chemical Plant Co., Ltd.
  • 15.3. Zhejiang Shengda Bio-Pharm Co., Ltd.
  • 15.4. Xinfa Pharmaceutical Co., Ltd.
  • 15.5. Jiangxi Tianxin Pharmaceutical Co., Ltd.
  • 15.6. Hebei Jiheng (Group) Pharmaceutical Co., Ltd.

16. Strategic Recommendations

17. About Us & Disclaimer